| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $434.2M | +19.5% |
| R&D Expense | $648.4M | -8.1% |
| SG&A Expense | $309.8M | +11.4% |
| Operating Income | -$569.2M | +12.3% |
| Pre-tax Income | -$608.5M | +13.3% |
| Income Tax | -$1.8M | -132.0% |
| Net Income | -$606.6M | +14.2% |
| EPS (Basic) | -$8.25 | +18.5% |
| EPS (Diluted) | -$8.25 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $213.6M | +60.7% |
| Accounts Receivable | $73.4M | +81.5% |
| Inventory | $34.0M | +26.9% |
| Current Assets | $732.2M | -17.2% |
| Total Assets | $1.49B | -3.5% |
| Current Liabilities | $280.4M | +7.4% |
| Total Liabilities | $1.22B | +1.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$474.8M | -24.8% |
| Capital Expenditures | $44.3M | -61.9% |
| Investing Cash Flow | $168.0M | +157.6% |
| Financing Cash Flow | $388.1M | -22.6% |
| Free Cash Flow | -$519.1M | -4.5% |
| +18.5% |
| Stockholders' Equity |
| $275.4M |
| -21.9% |